LUMO - Lumos Pharma Inc Stock Price, Fair Value and News

$4.35-0.03 (-0.68%)

Delayed as of 03 Dec 2024, 11:48 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

LUMO Price Action

Last 7 days

1.9%

Last 30 days

0.2%

Last 90 days

11.5%

Trailing 12 Months

44.1%

LUMO RSI Chart

LUMO Valuation

Market Cap

37.9M

Price/Earnings (Trailing)

-1.08

Price/Sales (Trailing)

17.18

EV/EBITDA

-0.74

Price/Free Cashflow

-1.2

LUMO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

LUMO Fundamentals

LUMO Revenue

Revenue (TTM)

2.2M

Rev. Growth (Yr)

10.3K%

Rev. Growth (Qtr)

48.77%

LUMO Earnings

Earnings (TTM)

-34.9M

Earnings Growth (Yr)

10.04%

Earnings Growth (Qtr)

1.11%

LUMO Profitability

EBT Margin

-1486.39%

Return on Equity

-710.54%

Return on Assets

-199.97%

Free Cashflow Yield

-83.61%

LUMO Investor Care

Shares Dilution (1Y)

9.27%

Diluted EPS (TTM)

-4.28

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.5M	1.5M	2.2M	0
2023	2.1M	2.2M	1.7M	2.1M
2022	553.3K	876.5K	1.2M	1.5M
2021	0	188.7K	209.3K	230.0K
2020	744.0K	552.0K	360.0K	168.0K
2019	9.6M	6.7M	3.8M	936.0K
2018	35.9M	27.7M	22.4M	12.5M
2017	32.8M	41.2M	31.3M	28.7M
2016	35.0M	29.6M	30.7M	35.8M
2015	191.8M	210.9M	230.1M	68.5M
2014	1.1M	1.1M	86.8M	172.6M
2013	1.5M	1.2M	1.1M	1.1M
2012	1.7M	1.8M	1.7M	1.7M
2011	2.0M	2.0M	1.9M	1.9M
2010	0	0	1.5M	2.1M
2009	0	0	0	934.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About Lumos Pharma Inc

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its primary product candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 3 clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

CEO	Mr. Richard J. Hawkins
WEBSITE	https://lumos-pharma.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	32

Lumos Pharma Inc Frequently Asked Questions

What is the ticker symbol for Lumos Pharma Inc? What does LUMO stand for in stocks?

LUMO is the stock ticker symbol of Lumos Pharma Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Lumos Pharma Inc (LUMO)?

As of Mon Dec 02 2024, market cap of Lumos Pharma Inc is 37.88 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LUMO stock?

You can check LUMO's fair value in chart for subscribers.

Is Lumos Pharma Inc a good stock to buy?

The fair value guage provides a quick view whether LUMO is over valued or under valued. Whether Lumos Pharma Inc is cheap or expensive depends on the assumptions which impact Lumos Pharma Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LUMO.

What is Lumos Pharma Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Dec 02 2024, LUMO's PE ratio (Price to Earnings) is -1.08 and Price to Sales (PS) ratio is 17.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LUMO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Lumos Pharma Inc's stock?

In the past 10 years, Lumos Pharma Inc has provided -0.193 (multiply by 100 for percentage) rate of return.